RATIFY 10-Yr Follow-Up
CALGB 10603/RATIFY: 10-Yr Follow-up of Midostaurin vs Placebo Combined With Intensive CT for Newly Diagnosed FLT3-Mutant AML 

Released: December 10, 2024

Expiration: December 09, 2025

Activity

Progress
1
Course Completed